Pancreatic Cancer Research

ResearcherMichael E. DeBakey VA Medical CenterActive in the last 2 years

William E. Fisher

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5103393690. Sources: OpenAlex.

Their work

Papers
28 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
105
Papers, trials and grants by year

2011: 3 papers · 2012: 3 papers · 2013: 3 papers · 2014: 2 papers · 2015: 2 papers · 2016: 2 papers · 2017: 2 papers · 2018: 5 papers · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 28

  1. Detection of Pancreatic Cancer Using a Methylation-Specific PCR-Based Multi-Cancer Early Detection Test Co-author DOI 10.64898/2026.05.27.728292↗
  2. Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2022.02.058↗
  3. An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-… Co-author DOI 10.3390/biomedicines10020450↗
  4. Rapid diagnosis and tumor margin assessment during pancreatic cancer surgery with the MasSpec Pen technology. Co-author DOI 10.1073/pnas.2104411118↗
  5. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2018.11.012↗
  6. Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Co-author DOI 10.1016/j.surg.2018.08.003↗
  7. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. Co-author DOI 10.1016/j.jand.2017.07.005↗
  8. The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and D… Co-author DOI 10.1097/mpa.0000000000001037↗
  9. A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001169↗
  10. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the … Co-author DOI 10.1097/mpa.0000000000001170↗
  11. Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pan… Co-author DOI 10.1097/mpa.0000000000001171↗
  12. Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Co-author DOI 10.1016/j.surg.2017.05.003↗
  13. Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer. Co-author DOI 10.1016/j.ymthe.2016.10.016↗
  14. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  15. Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2016.1213933↗
  16. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2015.04.009↗
  17. Pancreatic cancer disparities in African Americans. Co-author DOI 10.1097/mpa.0000000000000323↗
  18. Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1371/journal.pone.0106289↗
  19. Pancreatic cancer: advances in treatment. Last author DOI 10.3748/wjg.v20.i28.9354↗
  20. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. Co-author DOI 10.1002/emmm.201302507↗
  21. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-12-3776↗
  22. Gene profile identifies zinc transporters differentially expressed in normal human organs and human pancreatic cancer. Co-author DOI 10.2174/1566524011313030009↗
  23. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Co-author DOI 10.1038/nature11547↗
  24. PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. Co-author DOI 10.1371/journal.pone.0040452↗
  25. Genomic sequencing of key genes in mouse pancreatic cancer cells. Co-author DOI 10.2174/156652412799218868↗
  26. Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival. Co-author DOI 10.1002/cncr.25858↗
  27. The promise of a personalized genomic approach to pancreatic cancer and why targeted therapies have missed the mark. Co-author DOI 10.1007/s00268-010-0949-7↗
  28. Engineered T cells for pancreatic cancer treatment. Co-author DOI 10.1111/j.1477-2574.2011.00344.x↗

Closest collaborators

The 25 strongest of 105 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. George Van Buren · 8 shared papers, 2014–2022 · strength 0.70
  2. Eric Jay Silberfein · 4 shared papers, 2015–2022 · strength 0.39
  3. Stephen Jacob Pandol · 5 shared papers, 2018 · strength 0.32
  4. Mark A. Nelson · 1 shared paper, 2026 · strength 0.26
  5. Hanh T. Pham · 1 shared paper, 2026 · strength 0.26
  6. Phil A. Hart · 4 shared papers, 2018 · strength 0.26
  7. Aida Habtezion · 3 shared papers, 2018 · strength 0.20
  8. Somala Mohammed · 3 shared papers, 2014–2017 · strength 0.20
  9. Zobeida Cruz‐Monserrate · 3 shared papers, 2018 · strength 0.20
  10. Suresh T. Chari · 3 shared papers, 2018 · strength 0.19
  11. José Serrano · 3 shared papers, 2018 · strength 0.18
  12. Steven J. Hughes · 3 shared papers, 2018 · strength 0.18
  13. Sudhir Srivastava · 3 shared papers, 2018 · strength 0.18
  14. Ziding Feng · 3 shared papers, 2018 · strength 0.18
  15. Jo Ann Rinaudo · 3 shared papers, 2018 · strength 0.18
  16. Kristi K. Snyder · 1 shared paper, 2022 · strength 0.17
  17. Robert G. Van Buskirk · 1 shared paper, 2022 · strength 0.17
  18. John M. Baust · 1 shared paper, 2022 · strength 0.17
  19. Ernest Ramsay Camp · 1 shared paper, 2022 · strength 0.16
  20. Onur Cagri Kutlu · 1 shared paper, 2022 · strength 0.16
  21. Townes A Mickel · 1 shared paper, 2022 · strength 0.16
  22. Nader Nabile Massarweh · 2 shared papers, 2017–2019 · strength 0.16
  23. Hop S. Tran Cao · 2 shared papers, 2017–2019 · strength 0.16
  24. Qizhi Cathy Yao · 4 shared papers, 2013–2016 · strength 0.15
  25. Francis Charles Brunicardi · 5 shared papers, 2011–2013 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.